Aiming to Push Genomics Forward in New Study
Monday, January 13, 2014 - 22:20
in Biology & Nature
Regeneron Pharmaceuticals will sequence DNA from about 100,000 patients of Geisinger Health System in Pennsylvania, seeking genetic variants linked to diseases that may provide clues to developing new drugs.